Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$86,250.00

The dopamine D1-D2 receptor heteromer and the epigenetic regulation of gene expression: a role in schizophrenia and drug addiction

FY 2009-10

Summary
Epigenetics is presently one of the fastest growing fields of neuroscience research as the important role of epigenetic modifications in neuropsychiatric dopamine disorders, such as schizophrenia and addiction, is becoming readily apparent. Yet, the involvement of the specific dopamine receptor complexes in mediating these epigenetic changes remains completely unexplored. Our recent findings showed that dopamine D1 and D2 receptors form a Gq-linked D1-D2 heteromeric complex, whose activation induces brain derived neurotrophic factor (BDNF) synthesis and release in nucleus accumbens. We also showed that D1-D2 heteromers are localized throughout the mesolimbic system and basal ganglia nuclei and exhibit sensitization in striatum following chronic amphetamine treatment in rats and in schizophrenia globus pallidus. As a role for BDNF signaling in schizophrenia and addiction has recently emerged, these data implicate the D1-D2 heteromer as a link between BDNF signaling and neuropsychiatric disorders involving elevated dopamine transmission. We propose to study the role of the dopamine D1-D2 heteromer in the epigenetic regulation of BDNF expression in rats after acute and persistent hyperdopaminergia using psychostimulant administration, or in the dopamine transporter knock-out mouse. Further we will elucidate whether the D1-D2 heteromer has a functional role in regulating behavioral activity and chromatin remodeling at the gene promoters c-fos and FosB that are induced by elevated dopamine transmission. Positive findings in our research would establish a role for the D1-D2 heteromer in the epigenetic regulation of BDNF gene expression, link psychostimulant-induced changes in chromatin remodeling and BDNF gene expression to the D1-D2 heteromer, and identify the D1-D2 heteromer and/or specific epigenetic factors as novel therapeutic targets in disorders whose pathophysiologies result from enhanced dopamine transmission, such as in schizophrenia and drug addiction.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
199684
Name
Perreault Melissa L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The dopamine D1-D2 receptor heteromer and the epigenetic regulation of gene expression: a role in schizophrenia and drug addiction
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$86,250
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Behaviour; Brain-Derived Neurotrophic Factor; Chip; Dopamine D1-D2 Heteromer; Epigenetics; Gene Expression; Hyperdopaminergia; In Situ Hybridization; Psychostimulants; Schizophrenia
Abstract
Epigenetics is presently one of the fastest growing fields of neuroscience research as the important role of epigenetic modifications in neuropsychiatric dopamine disorders, such as schizophrenia and addiction, is becoming readily apparent. Yet, the involvement of the specific dopamine receptor complexes in mediating these epigenetic changes remains completely unexplored. Our recent findings showed that dopamine D1 and D2 receptors form a Gq-linked D1-D2 heteromeric complex, whose activation induces brain derived neurotrophic factor (BDNF) synthesis and release in nucleus accumbens. We also showed that D1-D2 heteromers are localized throughout the mesolimbic system and basal ganglia nuclei and exhibit sensitization in striatum following chronic amphetamine treatment in rats and in schizophrenia globus pallidus. As a role for BDNF signaling in schizophrenia and addiction has recently emerged, these data implicate the D1-D2 heteromer as a link between BDNF signaling and neuropsychiatric disorders involving elevated dopamine transmission. We propose to study the role of the dopamine D1-D2 heteromer in the epigenetic regulation of BDNF expression in rats after acute and persistent hyperdopaminergia using psychostimulant administration, or in the dopamine transporter knock-out mouse. Further we will elucidate whether the D1-D2 heteromer has a functional role in regulating behavioral activity and chromatin remodeling at the gene promoters c-fos and FosB that are induced by elevated dopamine transmission. Positive findings in our research would establish a role for the D1-D2 heteromer in the epigenetic regulation of BDNF gene expression, link psychostimulant-induced changes in chromatin remodeling and BDNF gene expression to the D1-D2 heteromer, and identify the D1-D2 heteromer and/or specific epigenetic factors as novel therapeutic targets in disorders whose pathophysiologies result from enhanced dopamine transmission, such as in schizophrenia and drug addiction.
Competitiondate
201002
Approvedterm2
1 yr 11 mths
Pinamesdelim
Perreault, Melissa L
Approvedterm
1 an 11 mois
Cihrcontribution2
~ $86,250~ $0~